Biotechnology and Its Applications

Table of Contents
(tap to open/close)

Biotechnology Applications

This chapter Biotechnology and Its Applications, focuses on the diverse applications of biotechnology in agriculture, medicine, and ethical considerations, including advancements like GMOs, gene therapy, and transgenic animals.

Introduction to Biotechnology

  • Biotechnology involves industrial-scale production of biopharmaceuticals and biological products using genetically modified microbes, fungi, plants, and animals.
  • Its applications extend across agriculture, medicine, industry, and environmental management.
  • Major Areas of Application
  1. Therapeutics
  2. Diagnostics
  3. Genetically Modified Crops
  4. Processed Food
  5. Bioremediation
  6. Waste Treatment
  7. Energy Production

Three Critical Research Areas in Biotechnology

  1. Best Catalyst Development
    • Providing improved organisms (commonly microbes) or purified enzymes that function efficiently as biological catalysts.
  2. Creation of Optimal Conditions
    • Designing engineered systems that maintain ideal environmental conditions (temperature, pH, nutrients, oxygen) for catalyst activity.
  3. Downstream Processing
    • Developing efficient technologies to isolate, purify, and formulate proteins or organic compounds after biosynthesis.

Biotechnological Applications in Agriculture

Need for Improvement
  • Rapid population growth demands higher agricultural productivity. Traditional methods have limitations in sustaining long-term yield improvement.
Green Revolution
  • Impact:
    • Tripled food production globally.
  • Limitations:
    • Still insufficient for growing population.
    • Heavy dependence on agrochemicals.
    • Increased cost of cultivation.
    • Environmental degradation.
  • Further yield improvement using conventional breeding is limited.
Options for Increasing Food Production

Three major approaches are followed:

1. Agrochemical-Based Agriculture

  • Description
    • Use of synthetic fertilizers, pesticides, and high-yielding varieties.
  • Advantages
    • Rapid productivity increase.
    • Effective pest and disease control.
  • Disadvantages
    • Expensive inputs.
    • Soil degradation and water contamination.
    • Environmental imbalance.

2. Organic Agriculture

  • Description
    • Relies on natural inputs, crop rotation, biofertilizers, and biopesticides.
  • Advantages
    • Environmentally sustainable.
    • Reduces chemical contamination.
  • Disadvantages
    • Higher production cost.
    • Generally lower yield compared to conventional methods.

3. Genetically Engineered Crop-Based Agriculture

  • Description
    • Uses genetically modified organisms (GMOs) developed through recombinant DNA technology.
  • This approach addresses limitations of conventional breeding.

Genetically Modified Organisms (GMOs)

  • Definition
    • GMOs are organisms whose genetic material has been deliberately altered using genetic engineering techniques.
  • They may include:
    1. Plants
    2. Animals
    3. Microbes
  • Transgene:
    • A foreign gene introduced into an organism’s genome is called a transgene.
    • Organisms expressing transgenes are called transgenic organisms.
Genetically Modified Crops
  • Definition
    • GM crops contain and express one or more desirable foreign genes to improve specific traits.

Major Benefits of GM Crops

  1. Tolerance to Abiotic Stresses
    • Crops become resistant to:
      • Drought
      • Salinity
      • Cold
      • Heat
  2. Reduced Dependence on Chemical Pesticides
    • Pest-resistant crops reduce pesticide usage.
  3. Reduced Post-Harvest Losses
    • Example: Flavr Savr tomato — delayed fruit softening.
  4. Improved Mineral Use Efficiency
    • Enhances nutrient uptake.
    • Prevents early exhaustion of soil fertility.
  5. Enhanced Nutritional Value
    • Example: Golden rice enriched with Vitamin A.
  6. Industrial Applications
    • GM plants are engineered to produce:
      • Starch
      • Biofuels
      • Pharmaceutical proteins

Some related concepts (not mentioned in NCERT)

Tissue Culture
  • Definition
    • Growing whole plants from small plant parts (explants) under sterile laboratory conditions.
  • Principle
    • Totipotency
      • Every plant cell has the genetic potential to regenerate into a complete plant.
  • Nutrient Requirements
    • Culture medium must contain:
      • Carbon source (e.g., sucrose)
      • Inorganic salts
      • Vitamins
      • Amino acids
      • Growth regulators (auxins and cytokinins)
Micropropagation
  • Definition
    • Rapid production of large numbers of genetically identical plants (somaclones).
  • Applications
    • Commercially used in crops such as:
      • Banana
      • Tomato
      • Apple
Production of Virus-Free Plants
  • Principle
    • Meristem tissue is usually virus-free.
  • Method
    • Meristem culture is used to regenerate healthy plants from infected stoc
    • Successfully applied in:
      • Banana
      • Sugarcane
      • Potato
Somatic Hybridisation
  • Definition
    • Fusion of protoplasts (plant cells without cell walls) from different plant varieties to produce hybrid cells.
  • Process
    1. Cell wall removal → Protoplast formation
    2. Fusion of protoplasts
    3. Regeneration into hybrid plant
  • Example
    • Pomato (potato + tomato), though not commercially successful.
Conceptual Summary
  • Biotechnology applications in agriculture aim to:
    • Increase yield
    • Reduce chemical input
    • Improve stress tolerance
    • Enhance nutritional value
    • Ensure environmental sustainability
  • Genetically engineered crops provide a promising long-term solution to food security challenges.

Pest-Resistant Plants (Biopesticide-Based Strategy)

Concept

  • Genetically engineered plants can be made resistant to insect pests.
  • This reduces dependence on chemical pesticides and minimizes environmental damage.
  • Two major biotechnological strategies:
    1. Bt toxin–based insect resistance
    2. RNA interference (RNAi)–based nematode resistance
I. Bt Toxin–Based Insect Resistance
  • Source Organism
    • Bacillus thuringiensis (Bt), a soil bacterium.
  • Principle
    • Certain strains of Bt produce insecticidal proteins that are toxic to specific insect groups.
    • These proteins are encoded by cry genes.
    • When introduced into plants, these genes enable the plant to produce insecticidal proteins internally.
  • Target Insect Groups
    • Lepidopterans (tobacco budworm, armyworm, bollworms)
    • Coleopterans (beetles)
    • Dipterans (flies, mosquitoes)

Bt toxins are insect-group specific.

Nature of Bt Toxin

  • Protein Crystals
    • During a specific growth phase, Bt forms crystalline inclusions containing insecticidal proteins.
  • Inactive Protoxin
    • In bacteria, the toxin exists in inactive form (protoxin).
  • Activation in Insect Gut
    • Insect ingests Bt toxin.
    • Alkaline pH of insect midgut solubilizes crystals.
    • Protoxin is converted into active toxin.

Mode of Action

  1. Binding
    • Activated toxin binds to receptors on midgut epithelial cells.
  2. Pore Formation
    • Toxin creates pores in gut epithelial membrane.
  3. Cell Damage
    • Cells swell
    • Membrane ruptures (lysis)
    • Gut lining is destroyed
  • Result
    • Insect stops feeding and dies.

Bt Gene Incorporation into Crops

  • Specific cry genes are isolated from Bt and inserted into crop plants using suitable vectors.

Examples of cry Genes and Target Pests

  • cryIAc and cryIIAb → Control cotton bollworms
  • cryIAb → Protects corn against corn borer

Example Crops

  • Bt cotton
  • Bt corn
  • Bt rice
  • Bt tomato
  • Bt potato
  • Bt soybean

Note: Bt cotton was the first transgenic crop introduced in India.

II. RNA Interference (RNAi)–Based Nematode Resistance
  • Problem
    • Meloidogyne incognita infects roots of tobacco and other crops, leading to significant yield reduction.
  • Principle of RNA Interference (RNAi)
    • RNA interference (RNAi) is a natural cellular defense mechanism present in eukaryotes.
    • It inhibits gene expression by degrading or blocking specific mRNA molecules, thereby preventing translation.
    • Source of complementary RNA may include viruses or mobile genetic elements (transposons).

Concept of Sense and Anti-Sense RNA

  1. Sense RNA → Normal mRNA used for translation.
  2. Anti-sense RNA → Complementary RNA strand.

When both are present:

  • They anneal to form double-stranded RNA (dsRNA).
  • dsRNA cannot be translated.
  • Target gene expression is silenced.

Mechanism in Transgenic Plants

  • Step 1: Introduction of Nematode-Specific Gene
    • Using Agrobacterium tumefaciens vectors, a DNA sequence producing anti-sense RNA is introduced into the plant genome.
  • Step 2: Formation of Double-Stranded RNA
    • The transgenic plant produces both sense and anti-sense RNA.
    • These complementary strands anneal to form double-stranded RNA (dsRNA).
  • Step 3: Gene Silencing
    • dsRNA activates the RNAi pathway.
    • The mRNA of nematode-specific genes is degraded or blocked.
  • Result
    • The nematode cannot survive in transgenic plants expressing interfering RNA.
    • Thus, the plant becomes resistant to nematode infection.

RNAi in very detailed (not mentioned in NCERT)

RNA INTERFERENCE (RNAi)

“Search and Destroy” Defense Mechanism

  • Definition
    • RNAi is a method of cellular defense in all eukaryotic organisms.
    • In biotechnology, RNAi is used to create transgenic tobacco plants resistant to the nematode Meloidogyne incognita.

PART I – THE COMPONENTS (THE CAST)

  1. The Target
    • A vital gene from the nematode (Meloidogyne incognita).
    • This gene is essential for survival (e.g., metabolism or reproduction).
  2. The Vector
    • Agrobacterium tumefaciens
    • Acts as a “natural genetic engineer” to deliver nematode DNA into tobacco plant.
  3. The Host
    • Tobacco plant
    • Modified to produce the RNAi “weapon.”

PART II – THE MECHANISM (STEP-BY-STEP)

PHASE I – Creating the Transgenic Plant

  • Step 1 – Isolation
    • Vital gene identified from nematode.
  • Step 2 – rDNA Construction
    • Gene inserted into Agrobacterium Ti-plasmid.
    • Crucial design:
      • DNA inserted so that both sense and anti-sense RNA are produced in host plant.
  • Step 3 – Transformation
    • Agrobacterium infects tobacco plant cells.
      DNA integrates into plant genome.
  • Step 4 – Formation of dsRNA
    • Inside plant cells:
    • Sense RNA + Anti-sense RNA (complementary strands)
      • Bind together
      • Form double-stranded RNA (dsRNA).

PHASE II – The Nematode Attack

  • Step 1 – Ingestion
    • Nematode feeds on tobacco root cell sap.
  • Step 2 – SID Proteins (“Gut Tunnels”)
    • Nematodes possess transmembrane proteins called SID proteins
    • SID proteins – Systemic RNA Interference Deficient proteins.
    • Function:
      • Allow intact dsRNA to pass from gut into body cells
      • Transport dsRNA into haemolymph
      • dsRNA not digested

PHASE III – Gene Silencing Inside Nematode Cells

Once dsRNA enters nematode cells → Dicer–RISC pathway triggered.

  • Step A – Dicer (The “Shredder”)
    • Dicer enzyme recognizes dsRNA.
    • Cuts dsRNA into small fragments:
    • 21–23 nucleotides long
      • Called siRNA (small interfering RNA).
  • Step B – RISC (RNA-Induced Silencing Complex)
    • siRNA loaded into RISC protein complex.
  • Step C – Unwinding
    • RISC unzip/unwind dsRNA (siRNA):
      • Retains one strand (Guide strand)
      • Discards other strand
  • Step D – Target Recognition and Cleavage
    • RISC uses guide strand to locate complementary nematode mRNA.
    • Argonaute enzyme inside RISC:
      • Binds mRNA
      • Slices mRNA into pieces

FINAL RESULT

  • Nematode mRNA destroyed → Cannot be translated.
  • No essential protein formed → Nematode cannot survive.
  • Plant remains protected.

KEY DEFINITIONS

TermRole in RNAi
dsRNATrigger molecule initiating silencing
DicerEndoribonuclease that dices dsRNA into siRNA
RISCProtein complex that identifies and slices target mRNA
Sense/Anti-senseComplementary RNA strands forming dsRNA
SID ProteinsTransport dsRNA from nematode gut into cells

WHY DON’T HUMANS GET AFFECTED?

  • Humans lack SID transporter proteins found in nematodes.
  • Human digestive system contains large quantity of RNase enzymes that rapidly degrade RNA.
  • Nematode gut is specifically permeable to dsRNA.

HOW IS dsRNA PRODUCED IN PLANTS?

  • Usually ssRNA is produced during Transcription process of CENTRAL DOGMA.
  • But dsRNA produced by Two engineering strategies:

1. Two-Promoter Strategy (“Mirror Method”)

  • DNA inserted between two promoters facing each other.
  • Promoter A → Produces Sense RNA.
  • Promoter B → Produces Anti-sense RNA.
  • Complementary strands bind → dsRNA formed.

2. Inverted Repeat Strategy (“Hairpin Method”)

  • DNA arranged as:
  • Sense — Spacer — Anti-sense
  • Single long RNA transcribed.
  • RNA folds back due to complementarity.
  • Forms Hairpin RNA (shRNA).
    • Stem = dsRNA
    • Loop = Spacer
  • Most commonly used method in research.

Single Line NCERT Statement

  • “The DNA was introduced such that it produced both sense and anti-sense RNA in the host cells. These two RNAs, being complementary, formed dsRNA that initiated RNAi.”

RNAi AS EUKARYOTIC DEFENSE

Why Exclusive to Eukaryotes?

  • Eukaryotes have complex cytoplasm and nucleus
  • Require regulation of mRNA transport
  • Dicer and RISC are large protein complexes

Prokaryotic Alternative

  • Bacteria use CRISPR-Cas9 system.
  • CRISPR uses small RNA guides to destroy viral DNA.

NATURAL ROLES OF RNAi

  1. Antiviral Defense
    • Plants and insects shred viral RNA via Dicer.
  2. Control of Transposons
    • Silences jumping genes.
    • Maintains genome stability.
  3. Gene Regulation (miRNA)
    • MicroRNA (miRNA) silences specific genes during development.

ARTIFICIAL APPLICATIONS OF RNAi

In Plants: Flavr Savr Tomato

  • Problem:
    • Polygalacturonase (PG) enzyme breaks down pectin (fruit wall).
    • Tomato softens and rots quickly.
    • Farmers pick green tomatoes for transport and ripe them with Ethylene.
      • These Ethylene ripe tomatoes lacks natural flavor.
  • Solution:
    • PG gene isolated.
    • Anti-sense DNA inserted.
    • Sense RNA + Anti-sense RNA → dsRNA formed.
    • RNAi machinery destroys PG mRNA thus stopping translation of it..
  • Result:
    • Firmer skin tomato
    • Longer shelf life
    • Vine-ripened flavor
  • Approved in 1994 but Removed from market due to economic reasons, not safety concerns..

Non-Browning Apples

  • Silencing polyphenol oxidase (PPO).

Virus Resistant Papaya

  • Silencing viral replication genes.

In Humans (Medicine)

  • Patisiran
    • First FDA-approved RNAi drug.
    • Treats Hereditary Transthyretin Amyloidosis.
  • Inclisiran
    • Silences PCSK9 gene.
    • Improves LDL cholesterol removal.
  • Experimental Cancer Therapy
    • Silencing oncogenes.

COMPARISON: RESTRICTION ENZYMES vs RNAi

FeatureRestriction EnzymesRNAi
Found inProkaryotesEukaryotes
TargetDNARNA
Natural roleDefense against bacteriophagesDefense against viruses & transposons
Biotech useMolecular scissorsGene silencing
Additional Applications of Transgenic Plants
  • Herbicide resistance (e.g., early tobacco resistant to glyphosate)
  • Delayed fruit ripening (Flavr Savr tomato – reduced polygalacturonase activity)
  • Production of biopharmaceuticals (e.g., hirudin from Brassica napus)
Advantages of Transgenic Pest-Resistant Plants
  • Reduced pesticide usage
  • Lower environmental pollution
  • Target-specific insect control
  • Increased crop yield
  • Reduced post-harvest losses
  • Improved nutrient efficiency
Potential Risks and Concerns
  • Possible allergic or toxic metabolites
  • Transfer of transgenes to related wild species
  • Development of resistant insect populations
  • Ecological imbalance

Hence, biosafety evaluation is essential.

Key Points

  • Bt toxin and RNA interference represent two major molecular strategies for developing pest-resistant crops.
  • These approaches:
    • Reduce chemical pesticide dependence
    • Improve crop protection
    • Enhance agricultural sustainability

CRISPR (not mentioned in NCERT)

CRISPR – MOLECULAR SCISSORS
  • Basic Concept
    • CRISPR acts as molecular scissors.
    • Primary action:
      • Cuts DNA
    • Certain variants:
      • Can also target RNA

MAJOR CRISPR SYSTEMS

  1. CRISPR-Cas9
    • Most commonly used system
    • Uses guide RNA (gRNA)
    • Finds specific DNA sequence
    • Cuts both strands (double-stranded break)
    • Used for precise gene editing
  2. CRISPR-Cas12 (Cpf1)
    • Expands toolkit beyond Cas9
    • Can cut DNA
    • Also capable of targeting RNA
  3. CRISPR-Cas13
    • Specifically targets RNA
    • Functions similarly to RNA-targeting systems

Mechanism (General)

  • Guide RNA → Directs Cas enzyme to target sequence
  • Cas enzyme → Makes cut
  • Result:
    • Gene inactivation
    • Gene repair
    • Sequence modification

Applications

  • Gene editing
  • Detection of RNA/DNA from viruses
  • Cancer cell detection

ORIGIN OF CRISPR

  • Natural Occurrence
    • CRISPR is exclusively found in:
      • Prokaryotes (Bacteria, Archaea)
  • Natural Role
    • Acts as adaptive immune system in Bacteria.
    • Function:
      • Remembers viral DNA on encounter.
      • Archives viral sequence (Spacer)
      • Cuts viral DNA upon re-infection
  • Eukaryotic Use
    • Eukaryotes do NOT naturally possess CRISPR.
    • When used in: Humans Plants or Animals
      • It is borrowed from bacteria and engineered to function in eukaryotic cells.

CRISPR vs RNA INTERFERENCE (RNAi)

CRISPR and RNAi both use guide molecules but are not equivalent systems.

FeatureCRISPR (Prokaryotic Origin)RNAi (Eukaryotic Origin)
Primary TargetUsually DNAmRNA
OutcomePermanent gene changeTemporary gene silencing
MechanismCas enzymes cut DNARISC complex degrades RNA
Natural GoalDefense against foreign DNAGene regulation & RNA virus defense

Conceptual Analogy

  • CRISPR → Erases blueprint (DNA permanently altered).
  • RNAi → Intercepts message (RNA destroyed, DNA intact).
  • Exception – Cas13
    • Cas13 targets RNA instead of DNA.
    • In this case, CRISPR-Cas13 functionally resembles RNAi.
    • However, molecular machinery remains different.

CRISPR vs RESTRICTION ENZYMES (RE)

Both are bacterial defense systems against bacteriophages.

  1. Type of Immunity
    • Restriction Enzymes → Innate immunity (fixed).
    • CRISPR → Adaptive immunity (learned via spacer acquisition).
  2. Target Recognition Mechanism
    • Restriction Enzymes:
      • Protein-DNA binding
      • Recognition determined by enzyme structure
    • CRISPR:
      • RNA-DNA base pairing
      • Guide RNA determines specificity
  3. Programmability
    • Restriction Enzymes:
      • Recognize fixed sequences
      • To change target → New protein required
    • CRISPR:
      • Same Cas protein
      • Change guide RNA to alter target
  4. Recognition Sequence Length
    • Restriction Enzymes:
      • Recognize short sequences (4–8 base pairs)
    • CRISPR:
      • Recognizes ~20 base pairs
    • Short sequences → Multiple cuts possible
    • Long sequence → High specificity

SUMMARY COMPARISON TABLE

FeatureRestriction EnzymesCRISPR-Cas9
Immune TypeInnateAdaptive
Recognition ToolProtein structureGuide RNA
Target Length4–8 bp~20 bp
VersatilityLimitedHighly programmable

Biotechnological Applications in Medicine

Recombinant DNA Technology in Healthcare
  • Impact
    • Recombinant DNA technology has revolutionised healthcare by enabling large-scale production of safe and highly effective therapeutic proteins.
  • Advantages over Conventional Sources
    • Avoids contamination from animal tissues
    • Minimises allergic and immunological reactions
    • Ensures uniform purity and quality
  • Current Status
    • Approximately 30 recombinant therapeutics are approved worldwide.
    • About 12 are currently marketed in India.

Initially, Escherichia coli was widely used as a host for recombinant protein production. Yeast is now increasingly preferred for certain therapeutic proteins.

Genetically Engineered Insulin (Humulin)
  • Medical Importance
    • Insulin is essential for the management of diabetes mellitus, particularly adult-onset diabetes.
  • Historical Background
    • 1921 – Frederick Banting and Charles Best first extracted insulin from pancreatic islets.
    • Later, insulin was obtained from cattle and pig pancreas.
  • Although effective, animal-derived insulin sometimes caused allergic reactions in patients.
  • Recombinant human insulin overcame this limitation.

Structure of Human Insulin

Mature insulin consists of:

  • Two polypeptide chains:
    1. A-chain (21 amino acids)
    2. B-chain (30 amino acids)
  • Linked by disulphide bridges
  • Total amino acids = 51

Proinsulin

  • In humans, insulin is first synthesised as proinsulin.
  • Proinsulin contains:
    1. A-chain
    2. B-chain
    3. C-peptide (33 amino acids)
  • During maturation, the C-peptide is removed to form active insulin.

Challenge in Recombinant Insulin Production

  • The major challenge was producing mature insulin in the correct form with proper disulphide bond formation.
Production of Recombinant Insulin (Humulin)
  • Year: 1983
  • Company: Eli Lilly

Strategy

  • DNA sequences for A-chain and B-chain were synthesised.
  • Each gene was inserted separately into plasmids of E. coli.
  • Bacteria produced A and B polypeptides independently.
  • Chains were extracted and purified.
  • Disulphide bonds were artificially formed between the chains.

Result

  • Functional human insulin (Humulin) was successfully produced.

Impact

  • Enabled large-scale production.
  • Reduced allergic reactions.
  • Improved diabetes management worldwide.

Human Insulin Detailed (not mentioned in NCERT)

STRUCTURE OF HUMAN INSULIN

Basic Composition

  • Human insulin consists of:
    1. Two polypeptide chains
    2. Total of 51 amino acids
  • Chain A → 21 amino acids
  • Chain B → 30 amino acids
  • Total → 51 amino acids

Disulfide Bonds

  • The chains are held together by:
    • Two interchain disulfide bonds (between A and B chains)
    • One intrachain disulfide bond (within Chain A)

INSULIN BIOSYNTHESIS – NATURAL PROCESS IN HUMAN BODY

1. Preproinsulin (The Raw Form)

  • First synthesized as a single long polypeptide chain called preproinsulin.
  • It contains:
    • Signal peptide
    • B chain
    • C-peptide
    • A chain

2. Proinsulin (The Folding Stage)

  • After removal of the signal peptide → Proinsulin is formed.
  • Structure:
    • B chain
    • C-peptide
    • A chain
  • The C-peptide acts as:
    • Spacer/Hinge
  • This alignment allows A and B chains to come close enough for disulfide bonds to form.
  • Proinsulin folds like a hairpin.

3. Mature Insulin (Final Processing)

  • As proinsulin moves through:
    • Golgi apparatus
    • Storage vesicles
  • Proteolytic enzymes (proteases) cleave at two sites.
  • C-peptide is removed.
  • Remaining:
    • A chain
    • B chain
  • These are separate polypeptides but remain connected through previously formed disulfide bonds.
  • C-Peptide
    • Removed during maturation
    • Secreted into blood along with insulin (Doctors analyse it to get idea about overall insulin production)

Summary Table – Natural Insulin Maturation

StageComponentsStructure
PreproinsulinSignal + B + C + ASingle continuous chain
ProinsulinB + C + AFolded hairpin
Mature InsulinA chain + B chainTwo chains linked by disulfide bonds
Discarded PartC-peptideReleased into blood

RECOMBINANT HUMAN INSULIN – ELI LILLY (1983)

  • When Eli Lilly first produced recombinant human insulin (Humulin) in 1983, they did not use the natural proinsulin folding pathway.
  • Reason:
    • E. coli cannot naturally process and remove C-peptide from proinsulin.

STEPWISE PROCESS USED BY ELI LILLY

1. Identifying and Preparing the Gene

  • Instead of isolating the proinsulin gene, two separate DNA sequences were chemically synthesized:
    • One for Chain A (21 amino acids)
    • One for Chain B (30 amino acids)
  • C-peptide sequence was omitted.

2. Making Recombinant DNA

  • Plasmid Vectors
    • Chain A DNA inserted into one plasmid
    • Chain B DNA inserted into another plasmid
  • Fusion Proteins
    • To protect small insulin chains from degradation:
    • Attached to larger bacterial protein
    • Example: β-galactosidase

3. Fermentation in E. coli

  • Recombinant plasmids introduced into separate batches of Escherichia coli
  • Bacteria acted as biological factories
  • Produced Chain A and Chain B separately

4. Extraction and Purification

  • Bacteria harvested
  • Cells broken open
  • Insulin chains extracted
  • If fusion proteins used:
    • Chemical treatment (e.g., cyanogen bromide)
    • Snipped insulin chains from carrier protein

5. Final Assembly (Artificial Folding)

  • Since no C-peptide hinge was present:
    • Purified Chain A and Chain B mixed in laboratory
    • Chemical conditions induced disulfide bond formation
    • Correct structure achieved

COMPARISON – NATURAL VS ELI LILLY METHOD (1983)

Human BodyEli Lilly (Initial Method)
Makes one long chain (Proinsulin)Makes Chain A and Chain B separately
Folds into hairpinMixes chains in lab
Disulfide bonds form naturallyDisulfide bonds induced chemically
C-peptide removed by proteasesC-peptide never included

Gene Therapy

  • Definition
    • Gene therapy is a technique that involves the introduction of a functional gene into a patient’s cells to correct a genetic disorder.
  • Principle
    • A normal gene is delivered to compensate for a defective or missing gene.

First Clinical Gene Therapy

  • Year: 1990
    Patient: 4-year-old girl
    Disease: ADA (Adenosine Deaminase) deficiency
  • Disease Mechanism
    • ADA enzyme is essential for proper immune system function.
    • Its deficiency leads to Severe Combined Immunodeficiency (SCID).
  • Existing Treatments
    • Bone marrow transplantation (partially effective)
    • Enzyme replacement therapy (temporary relief)
  • Neither provides a permanent cure.

Steps of ADA Gene Therapy

  1. Isolation of Lymphocytes
    • Lymphocytes were isolated from the patient’s blood and cultured outside the body (in vitro).
  2. Introduction of Functional ADA Gene
    • Normal ADA cDNA inserted into a modified retroviral vector.
    • Viral genes replaced by ADA gene.
    • Retrovirus used to infect cultured lymphocytes.
  3. Expression
    • Modified lymphocytes began expressing ADA enzyme.
  4. Reintroduction
    • Genetically engineered lymphocytes were infused back into the patient.
  • Outcome
    • ADA activity partially restored.
    • Periodic infusions required since modified cells were not permanent.

Limitation and Future Possibility

  • If the ADA gene is introduced into early embryonic cells:
    • Correction could become permanent.
    • All body cells would carry the functional gene.

Gene Therapy in Detailed (not mentioned in NCERT)

GENE THERAPY FOR SCID (Severe Combined Immunodeficiency)
  • To determine the correct sequence for gene therapy in SCID, we follow the logical flow of genetic engineering:
  • Vector preparation → Cell modification → Integration → Reintroduction

STEP-BY-STEP SEQUENCE

  • Step 1 – Preparation of the Vector
    • Normal allele is inserted into a retrovirus.
      • Therapeutic gene (normal allele) placed into delivery vehicle
      • Retrovirus acts as vector
  • Step 2 – Infection / Transformation (Ex Vivo)
    • Retrovirus infects lymphocytes extracted from bone marrow of the patient and cultured.
      • Patient’s lymphocytes removed
      • Cultured in laboratory
      • Modified retrovirus introduced
  • Step 3 – Reverse Transcription & Integration
    • Retrovirus makes a DNA copy of its RNA.
    • This DNA carrying the normal allele gets inserted into the chromosome of the host cell.
      • Viral RNA → Converted to DNA
      • DNA integrates into host genome
  • Step 4 – Reintroduction
    • Engineered cells are injected into patient’s bone marrow.
      • Corrected cells returned to patient
      • Functional gene expressed

SUMMARY TABLE

StepActionPhase
1Inserting normal allele into retrovirusVector construction
2Virus infects extracted lymphocytesEx vivo infection
3Reverse transcription & genome integrationIntegration
4Modified cells returned to patientTransplantation
HOW HUMAN DNA IS INSERTED INTO A RETROVIRUS
  • Human gene = DNA
  • Retrovirus genome = RNA
  • They are not directly compatible.

1. Recombinant DNA Formation

  • Process begins with a DNA plasmid in laboratory.
    • Circular DNA plasmid created
    • Contains DNA version of retroviral genome
    • Restriction enzymes used to insert normal human allele
    • DNA ligase joins fragments
  • Result → Hybrid DNA (Human DNA + Viral DNA)

2. Production of Viral RNA

  • Hybrid DNA inserted into packaging cells.
  • Inside packaging cells:
    • Hybrid DNA transcribed into RNA
    • RNA contains viral genome + human gene
  • Packaging cell:
    • Wraps RNA into viral protein coat
    • Produces functional engineered retrovirus

3. Reverse Transcription in Patient Cells

  • When engineered retrovirus infects patient lymphocytes:
    • Viral RNA released
    • Reverse transcriptase converts RNA → DNA
    • Newly formed DNA includes normal human allele
    • DNA integrates into host chromosome
Molecular Diagnosis
  • Importance of Early Diagnosis
    • Early detection and understanding of a disease are crucial for effective treatment.
    • Traditional methods (serum and urine analysis) are not always sensitive for early detection.

Advanced Techniques

  1. PCR (Polymerase Chain Reaction)
    • Amplifies nucleic acids of pathogens, enabling detection even at very low concentrations before symptoms appear.
    • Applications:
      • Detection of HIV
      • Identification of cancer-related mutations
  2. ELISA (Enzyme-Linked Immunosorbent Assay)
    • Based on antigen–antibody interaction.
    • Detects infection by identifying:
      • Antigens of pathogens
      • Antibodies produced against pathogens
  3. Detection Using Radioactive Probes
    • Principle
      • A single-stranded DNA or RNA probe tagged with a radioactive molecule hybridizes with its complementary DNA sequence.
    • Detection
      • Hybridization is detected using autoradiography.
      • Clones with mutated genes do not bind the probe.
      • Such clones do not appear on the photographic film due to lack of complementarity.

Some DIAGNOSIS related concepts (not mentioned in NCERT)

EARLY DIAGNOSIS USING RECOMBINANT DNA TECHNOLOGY
  • Core Principle
    • Recombinant DNA Technology identifies pathogens or genetic mutations using:
      • Nucleic Acid Probes
    • It does not merely detect symptoms or pathogen load.
    • It detects the specific genetic signature of the pathogen — even when present in extremely small amounts.

NUCLEIC ACID PROBE METHOD

  • Definition
    • A nucleic acid probe is:
      • A single-stranded DNA or RNA fragment
      • Complementary to a known pathogen sequence
      • Labeled for detection

STEPWISE MECHANISM

  • Step 1: Probe Selection
    • Scientists design a single-stranded DNA/RNA sequence that is complementary to:
      1. A known pathogen sequence OR
      2. A specific mutated gene sequence
    • This ensures specificity.
  • Step 2: Radioactive / Fluorescent Tagging
    • The probe is labeled with:
      • A radioactive molecule OR
      • A fluorescent dye
    • This tagging allows detection after binding.
    • This labeled strand is called a PROBE.
  • Step 3: Hybridization
    • Patient sample processing:
      • Cells are denatured
      • DNA strands are separated
    • The probe is then mixed with the patient’s DNA.
    • If the pathogen DNA is present:
      • Complementary base pairing occurs
      • Probe binds (hybridizes) to target sequence
  • Step 4: Autoradiography
    • The sample is exposed to photographic film.
    • Positive Result: If the pathogen DNA is present:
      1. Probe hybridizes
      2. Radioactive signal exposes film
      3. Dark spot appears
    • Mutation Detection Principle: If a gene has mutated:
      • Probe sequence no longer matches
      • Hybridization does NOT occur
      • No dark spot forms
    • Thus: Mutated gene appears as a blank spot compared to normal control.

WHY THIS METHOD IS SUPERIOR TO NORMAL SERUM ANALYSIS

FeatureConventional Serum AnalysisRecombinant DNA / Probe Method
Detection BasisChemical changes or high pathogen countPresence of specific genetic sequence
Time of DetectionLate (after symptoms)Very early (even single infected cell)
SpecificityInfluenced by other bodily changesHighly sequence-specific

Key Concept

  • Particularly useful for:
    • Genetic disorders
    • Asymptomatic viral infections
    • Viruses integrated within host DNA

PCR (POLYMERASE CHAIN REACTION)

  • Principle
    • PCR is molecular amplification.
    • It multiplies specific DNA sequences when pathogen quantity is too low for detection.

Stepwise Mechanism

  1. Denaturation
    • DNA heated
    • Double strands separate
  2. Annealing
    • Specific primers bind to pathogen DNA
    • Primers are short DNA sequences designed to match only the pathogen.
  3. Extension
    • Taq polymerase synthesizes new DNA strands
    • Target DNA doubles

Amplification

  • Cycle repeated 30–40 times
  • Result:
    • Even one viral DNA molecule → billions of copies

Use Case

  • Detecting HIV before symptoms
  • Identifying COVID-19 viral RNA

ELISA (ENZYME LINKED IMMUNOSORBENT ASSAY)

  • Principle
    • Based on Antigen–Antibody interaction
    • Lock-and-key mechanism

Stepwise Mechanism

  1. Coating
    • Plate coated with:
      • Antibodies (to detect pathogen) OR
      • Antigens (to detect patient antibodies)
  2. Binding
    • Patient serum added
    • If matching protein present:
      • Binding occurs
  3. Enzyme-Linked Antibody
    • Second antibody linked to enzyme added
    • It binds to pathogen protein.
  4. Substrate Addition
    • Chemical substrate added
    • Enzyme reacts → Color change
  • Result
    • Color change (blue/yellow) = Positive result
    • Color intensity indicates quantity.
  • Use Case
    • Hepatitis screening
    • Malaria detection
    • Initial screening test for AIDS

COMPARISON – PCR vs ELISA

MethodDetectsKey Advantage
PCRNucleic acids (DNA/RNA)Extremely high sensitivity
ELISAProteins (antigens/antibodies)Fast, economical, batch processing

SUMMARY

  • Probe Method → Detects specific DNA sequence via hybridization.
  • PCR → Amplifies DNA to detectable levels.
  • ELISA → Detects proteins via antigen–antibody reaction.
Monoclonal Antibodies
  • Definition
    • Monoclonal antibodies are identical antibodies produced from a single clone of immune cells.
  • Production (Hybridoma Technology)
    1. Antigen injected into mouse or rat
    2. B-lymphocytes isolated
    3. Fused with myeloma cells
    4. Hybridoma cells produce specific antibodies indefinitely
  • Applications
    • Cancer therapy
    • Diagnostic tests
    • Targeted drug delivery

Conceptual Summary

Recombinant DNA technology in medicine enables:

  • Production of recombinant proteins (e.g., insulin)
  • Treatment of genetic disorders via gene therapy
  • Development of monoclonal antibodies
  • Large-scale, safe and precise therapeutic manufacturing

It represents one of the most transformative applications of modern biotechnology.

Transgenic Animals

  • Definition
    • A transgenic animal is one whose genome contains an artificially introduced foreign gene called a transgene.
  • The process of introducing DNA into animal cells is called transfection (in contrast to transformation used for microbes).
  • Over 95% of transgenic animals produced are mice due to their experimental advantages.
  • Common Transgenic Animals
    • Mice (most widely used)
    • Rats
    • Rabbits
    • Pigs
    • Sheep
    • Cows
    • Fish
Why Are Transgenic Animals Produced?

1. Study of Normal Physiology and Development

  • Purpose
    • To understand how genes regulate body functions and developmental processes.
  • Mechanism
    • Specific genes are introduced or altered to study their biological effects.
  • Example
    • Study of growth regulation using insulin-like growth factor genes.
  • Outcome
    • Helps determine the role of genes in growth, metabolism, and organ development.

2. Study of Human Diseases

  • Purpose
    • To understand gene contribution in disease development.
  • Approach
    • Animals are genetically modified to serve as models of human diseases.
  • Example
    • Cancer
    • Cystic fibrosis
    • Rheumatoid arthritis
    • Alzheimer’s disease
  • Benefit
    • Facilitates testing of new therapeutic strategies.

3. Production of Biological Products (Molecular Farming)

  • Purpose
    • To produce valuable human proteins economically.
  • Mechanism
    • Genes encoding therapeutic proteins are introduced into animals.
    • These proteins are secreted in milk, blood, or other body fluids.
  • Example
    • α-1-antitrypsin used for treating emphysema.
  • Applications
    • Treatment of phenylketonuria
    • Treatment of cystic fibrosis
    • Pharmaceutical protein production

Case Study – Transgenic Cow “Rosie” (1997)

  • Produced milk enriched with human α-lactalbumin.
  • Yield: Approximately 2.4 grams per litre.
  • Milk was nutritionally more suitable for human infants.

4. Vaccine Safety Testing

  • Purpose
    • To test safety of vaccines before human use.
  • Example
    • Transgenic mice used to evaluate polio vaccine safety.
  • Advantage
    • May reduce reliance on monkeys for vaccine testing.

5. Chemical Safety (Toxicity) Testing

  • Purpose
    • To assess safety of chemicals and drugs.
  • Method
    • Transgenic animals are engineered to be highly sensitive to toxins.
  • Outcome
    • Faster and more reliable toxicity assessment.

Examples of Specific Transgenic Animals (not mentioned in NCERT)

Transgenic Mice

  • Most preferred model due to:
    • Short gestation period
    • Large litter size
    • Short generation time
    • Availability of embryonic stem cell lines
  • First transgenic animal: Mouse carrying growth hormone gene – known as “Supermouse”.

Transgenic Cattle

  • Technique
    • Microinjection into fertilised ova.
  • Objectives
    • Increased milk/meat production
    • Improved milk protein composition
    • Reduced lactose and altered fat content
    • Disease resistance
    • Molecular farming

Transgenic Rabbits

  • Used for production of pharmaceutically important proteins such as:
    • Interleukin-2
    • Growth hormone
    • Tissue plasminogen activator
    • α-1-antitrypsin

Ethical Issues in Biotechnology

Need for Regulation
  • Unregulated genetic manipulation may cause:
    • Ecological imbalance
    • Biodiversity loss
    • Unpredictable biological consequences
  • Regulatory Authority in India
    • GEAC (Genetic Engineering Approval Committee)
  • Role
    • Evaluates GM research
    • Ensures biosafety
    • Approves public release of GM organisms
Major Bioethical Concerns
  1. Violation of Species Integrity
    • Transfer of genes across species boundaries.
  2. Environmental Risks
    • Unintended ecological effects
    • Gene flow to wild species
    • Disruption of ecosystems
  3. Animal Welfare
    • Suffering during experimentation
    • Ethical concern of treating animals as “biological factories”
  4. Human–Animal Genetic Exchange
    • Transfer of human genes into animals raises moral concerns.
  5. Risk of Accidental Biological Damage
    • Possibility of generating new pathogens.
Biopatents
  • Definition
    • A patent granted for biological entities or products derived from biological resources.
  • Examples of patented biological materials
    • Basmati rice
    • Neem
    • Turmeric
    • Black pepper
    • Indian mustard
    • Pomegranate
  • Concern
    • Traditional knowledge has sometimes been exploited without proper benefit sharing with indigenous communities.
    • Companies have patented plant varieties and herbal products traditionally used by farmers and local communities.
Biopiracy
  • Definition
    • Unauthorized commercial use or patenting of biological resources and traditional knowledge of other countries without compensation.
  • Example: Basmati Rice Case
    • In 1997, a US company obtained patent rights on a variety of Basmati rice derived from Indian germplasm through the US Patent and Trademark Office.
    • This raised concerns about:
      • Economic exploitation
      • Restriction of traditional farmers’ rights
      • Loss of rights of indigenous communities
    • Similar concerns were raised in cases involving turmeric and neem.

Biodiversity and Traditional Knowledge

  • Disparity
    • Developing countries are rich in biodiversity and traditional knowledge.
    • Industrialized nations often possess financial and technological power.
  • This imbalance has led to concerns about unfair exploitation of bio-resources.

Legal Measures

  • Need for Laws
    • To prevent unauthorized exploitation of genetic resources and traditional knowledge.
  • Actions Taken
    • Countries have introduced legal frameworks to protect biodiversity and ensure fair benefit sharing.
    • In India, amendments to the Indian Patents Act were introduced to address patent terms, emergency provisions, and research initiatives.
    • These measures aim to safeguard national interests and traditional knowledge.
Biowar (Biological Warfare)
  • Definition
    • Use of infectious agents or toxins as biological weapons.
  • Agents May Include
    • Bacteria (e.g., Bacillus anthracis)
    • Viruses (e.g., smallpox virus)
    • Toxins (e.g., botulinum toxin)
  • Characteristics
    • Relatively low cost
    • Difficult to detect early
    • High casualty potential
  • Defence Measures
    • Vaccination
    • Antibiotics
    • Protective equipment
    • Decontamination systems

Key Points

Biotechnology offers immense benefits but must be guided by:

  • Ethical standards
  • Biosafety regulations
  • Legal frameworks
  • Protection of biodiversity and traditional knowledge

Proper regulation ensures responsible use of biological resources and prevents biopiracy and misuse.

Chapter Summary

Core Concept

  • Biotechnology applies genetic engineering and bioprocess technology to develop useful products for agriculture, medicine, industry, and environmental management.
  • Recombinant DNA technology forms the molecular foundation of modern biotechnology.

Genetically Modified Organisms (GMOs)

  • GMOs are organisms whose genetic material has been deliberately altered using recombinant DNA techniques.
  • These include:
    • GM plants
    • Transgenic animals
    • Genetically modified microbes

Applications in Agriculture

  • GM plants have contributed to improved crop productivity and sustainability.
  • Major Advantages
    • Increased tolerance to abiotic stresses (drought, salinity, heat, cold)
    • Reduced dependence on chemical pesticides (e.g., Bt crops)
    • Reduced post-harvest losses (e.g., delayed ripening varieties)
    • Improved mineral use efficiency
    • Enhanced nutritional value (e.g., Vitamin A–enriched crops)
  • Biotechnological approaches such as Bt toxin expression and RNA interference provide targeted pest resistance.
  • These innovations support food security and reduce environmental damage.

Applications in Medicine

  • Recombinant DNA technology has transformed healthcare.
  • Major Contributions:

1. Mass Production of Recombinant Therapeutics

  • Therapeutic proteins identical to natural human proteins
  • Reduced risk of allergic reactions
  • High purity and consistency
  • Example:
    • Recombinant human insulin produced in bacteria is structurally identical to natural insulin and is widely used in diabetes management.

2. Gene Therapy

  • Gene therapy introduces functional genes into patient cells to correct genetic disorders.
    • Used in treatment of inherited diseases such as ADA deficiency
    • Viral vectors commonly used for gene delivery
    • Replaces defective genes with functional ones

3. Transgenic Animals

  • Transgenic animals serve as:
    • Models for studying human diseases
    • Systems for vaccine testing
    • Sources of pharmaceutical proteins
  • Disease models exist for:
    • Cancer
    • Cystic fibrosis
    • Rheumatoid arthritis
    • Alzheimer’s disease

Ethical and Regulatory Concerns

  • Genetic manipulation of living organisms raises significant ethical issues.
  • Major Concerns:
    • Environmental risks
    • Animal welfare issues
    • Gene transfer across species
    • Biodiversity loss
    • Commercial exploitation of biological resources
  • Regulatory bodies such as GEAC in India evaluate biosafety before public release of GM organisms.
  • Protection of biodiversity and traditional knowledge is essential to prevent biopiracy.

Integrated Understanding

  • Biotechnology integrates:
    • Molecular biology
    • Genetic engineering
    • Industrial-scale production
    • Medical innovation
    • Agricultural sustainability
  • While it offers powerful solutions to food insecurity and disease treatment, it must operate within strict ethical and regulatory frameworks.

Share this post with friends!

Leave a Reply

Your email address will not be published. Required fields are marked *

You cannot copy content of this page